Masimo Corporation - Common Stock (NQ:MASI)

179.95 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

What to Know About This Fund's $65 Million Homebuilder Bet Before a $47-Per-Share Buyout ↗

May 23, 2026

Tri Pointe Homes designs and sells single-family homes across key U.S. regions, supported by integrated mortgage and financial services.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund's $61 Million Self-Storage Bet as a $10.5 Billion Deal Nears ↗

May 23, 2026

This self storage REIT operates a nationwide portfolio, generating recurring revenue from rental and related services in key U.S. markets.

Via The Motley Fool

Topics Regulatory Compliance

CIBRA Capital Buys Stake in Allied Gold Stock ↗

April 27, 2026

Allied Gold Corporation operates a diversified mining business with core assets across Africa, producing and selling gold and silver.

Via The Motley Fool

Topics Regulatory Compliance

CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD) ↗

April 25, 2026

Amicus Therapeutics targets rare genetic diseases with proprietary therapies and a pipeline of treatments for underserved patient groups.

Via The Motley Fool

Topics Regulatory Compliance

Avanos Medical to be Acquired by American Industrial Partners for $1.27 Billion; Stock Surges 69%

April 14, 2026

The medical technology landscape witnessed a seismic shift on Tuesday as Avanos Medical (NYSE: AVNS) announced it has entered into a definitive agreement to be acquired by affiliates of American...

Via MarketMinute

Topics Economy

3 Small-Cap Stocks Walking a Fine Line

April 02, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

2 Unprofitable Stocks to Research Further and 1 Facing Headwinds

March 30, 2026

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...

Via StockStory

1 Healthcare Stock Worth Investigating and 2 That Underwhelm

March 27, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Via StockStory

1 Momentum Stock to Target This Week and 2 Facing Headwinds

March 23, 2026

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...

Via StockStory

This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition ↗

March 22, 2026

Masimo develops advanced noninvasive monitoring technologies used by hospitals and healthcare providers worldwide.

Via The Motley Fool

3 Overrated Stocks We Steer Clear Of

March 16, 2026

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...

Via StockStory

Topics Firearms

This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement ↗

March 15, 2026

This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.

Via The Motley Fool

Topics Regulatory Compliance

Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)

March 12, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitorin...

Via StockStory

Topics Artificial Intelligence

The $2.5 Trillion Tsunami: Why 2026 has Become the Year of the Megadeal

March 10, 2026

As of March 10, 2026, the United States financial markets are witnessing an unprecedented explosion in Mergers and Acquisitions (M&A) that has caught even the most optimistic analysts by surprise....

Via MarketMinute

Topics Artificial Intelligence Economy Government

1 Cash-Producing Stock on Our Buy List and 2 We Brush Off

March 04, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

1 Oversold Stock Set for a Comeback and 2 Facing Challenges

February 26, 2026

Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

Via StockStory

Topics Artificial Intelligence

Earnings To Watch: Masimo (MASI) Reports Q4 Results Tomorrow

February 24, 2026

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Thursday after the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence World Trade

Danaher’s $9.9 Billion Acquisition of Masimo: A Strategic Pivot to the Future of Patient Monitoring

February 19, 2026

In a move that has sent shockwaves through the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to acquire...

Via MarketMinute

Topics Artificial Intelligence Economy

Naya Capital Adds Masimo Shares ↗

February 19, 2026

Masimo supplies noninvasive monitoring tech to hospitals and care providers, serving both medical and consumer health markets worldwide.

Via The Motley Fool

Topics Regulatory Compliance

3 Reasons MASI is Risky and 1 Stock to Buy Instead

February 18, 2026

Masimo’s 19% return over the past six months has outpaced the S&P 500 by 12.2%, and its stock price has climbed to $174.61 per share. This was partly due to its solid quarterly results, and the run-up...

Via StockStory

Topics Stocks Supply Chain

3 Reasons MASI is Risky and 1 Stock to Buy Instead

February 17, 2026

Masimo has had an impressive run over the past six months as its shares have beaten the S&P 500 by 7.4%. The stock now trades at $174.58, marking a 13.4% gain. This was partly due to its solid...

Via StockStory

Topics Stocks Supply Chain

Danaher's $9.9 Billion Bet: Masimo Acquisition to Redefine the Diagnostics Landscape

February 17, 2026

In a move that signals a massive consolidation in the medical technology sector, Danaher Corporation (NYSE: DHR) announced on February 17, 2026, that it has entered into a definitive agreement to...

Via MarketMinute

Topics Artificial Intelligence Economy

Top movers analysis one hour before the close of the markets on 2026-02-17: top gainers and losers in today's session. ↗

February 17, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

February 17, 2026

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

February 17, 2026

Via Chartmill

Danaher Corporation (DHR): Navigating the Bioprocessing Thaw and the Masimo Pivot

February 17, 2026

As of February 17, 2026, Danaher Corporation (NYSE: DHR) finds itself at a pivotal juncture in its multi-decade evolution. Once the darling of the "compounding" investment community, the Washington,...

Via Finterra

Topics Artificial Intelligence Earnings Supply Chain

Tuesday's pre-market session: top gainers and losers ↗

February 17, 2026

Via Chartmill

Danaher Deal Finalized: Company To Acquire Masimo For $9.9 Billion In Cash ↗

February 17, 2026

The deal will entail Danaher paying $180 per share for Masimo, reflecting about 18 times Masimo’s projected 2027 earnings before interest, taxes, depreciation, and amortization.

Via Stocktwits

Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple ↗

February 17, 2026

Danaher is reportedly set to acquire Masimo, with the deal expected to be announced as early as Tuesday.

Via Stocktwits

Topics Intellectual Property

3 of Wall Street’s Favorite Stocks That Concern Us

January 01, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.